Sunshine Biopharma Inc. Disposal Group, Including Discontinued Operation, Interest Expense
Sunshine Biopharma Inc. (SBFM) reported Disposal Group, Including Discontinued Operation, Interest Expense of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-30.
Discontinued › Expense Statement › Interest Expense
us-gaap:DisposalGroupIncludingDiscontinuedOperationInterestExpense · last filed 2021-03-30
- Sunshine Biopharma Inc. disposal group, including discontinued operation, interest expense for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- Sunshine Biopharma Inc. disposal group, including discontinued operation, interest expense for fiscal 2019 was $3.52K, a 70.74% decline from fiscal 2018.
- Sunshine Biopharma Inc. disposal group, including discontinued operation, interest expense for fiscal 2018 was $12.02K.
| Period end | Disposal Group, Including Discontinued Operation, Interest Expense 12 month |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-30 |
| 2019-12-31 | $3.52K 10-K · filed 2021-03-30 |
| 2018-12-31 | $12.02K 10-K · filed 2020-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |